Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.
Hideo-Kajita A, Garcia-Garcia HM, Kuku KO, Beyene SS, Azizi V, Meirovich YF, Melaku GD, Dheendsa A, Brathwaite EJ, Desale S, Soud M, Dan K, Ozaki Y, Waksman R, Lipinski M. Hideo-Kajita A, et al. Among authors: dan k. Int J Cardiovasc Imaging. 2018 Sep;34(9):1349-1364. doi: 10.1007/s10554-018-1362-9. Epub 2018 May 19. Int J Cardiovasc Imaging. 2018. PMID: 29779179
Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.
Hideo-Kajita A, Rogers T, Buchanan K, Iantorno M, Gajanana D, Ozaki Y, Dan K, Kolm P, Brathwaite E, Beyene S, Melaku G, Meirovich Y, Dheendsa A, Garcia-Garcia HM, Torguson R, Waksman R. Hideo-Kajita A, et al. Among authors: dan k. Am J Cardiol. 2019 Apr 15;123(8):1228-1238. doi: 10.1016/j.amjcard.2019.01.031. Epub 2019 Jan 25. Am J Cardiol. 2019. PMID: 30738570
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
Hideo-Kajita A, Garcia-Garcia HM, Haude M, Joner M, Koolen J, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Teik LS, Escaned J, Azizi V, Kuku KO, Ozaki Y, Dan K, Waksman R. Hideo-Kajita A, et al. Among authors: dan k. Cardiovasc Revasc Med. 2019 May;20(5):392-398. doi: 10.1016/j.carrev.2019.02.019. Epub 2019 Feb 18. Cardiovasc Revasc Med. 2019. PMID: 31079817 Clinical Trial.
494 results